In patients younger than 19 with implantable cardioverter defibrillators, a lower body weight, indicating younger age, is ...
Medical Device Network on MSN
ZOLL introduces next-gen wearable cardioverter defibrillator in US
Medical devices and related software solutions maker ZOLL has introduced its next-generation LifeVest wearable cardioverter defibrillator (WCD) in the US. The latest device is the fifth LifeVest WCD, ...
ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the U.S. launch of ...
Zoll announced today that it launched its next-generation LifeVest wearable cardioverter defibrillator (WCD) in the U.S.
The risk associated with implantation of the implantable cardioverter-defibrillator (ICD) is often focused on the immediate complications of the procedure. The long-term risk of having an ICD, ...
1 in 5 with implantable cardioverter-defibrillator don't meet criteria for use. Jan. 4, 2011— -- One in five patients who receive the heart-shocking, life-saving devices known as implantable ...
Few medical therapies pose the issue of how to avoid sudden cardiac death as starkly as does the implantable cardioverter defibrillator — a device that is implanted like a pacemaker, which has been ...
Please provide your email address to receive an email when new articles are posted on . A novel adhesive-based wearable cardioverter defibrillator exceeded its safety and efficacy performance goals.
The indications for ICD implantation continue to expand; however, these devices are associated with complications related to the implantation procedure itself and morbidity caused by the normal and ...
What is Implantable Cardioverter Defibrillator (ICD)? The electrical activity of the heart keeps the heart beating constantly at a regular rhythm. A disturbance in this rhythm is called an arrhythmia.
A standard test of the implantable cardioverter defibrillator (ICD) is linked to significant thought-processing problems that improve for most patients within a year after the device is inserted, ...
LONDON--(BUSINESS WIRE)--Technavio’s global implantable cardioverter defibrillators (ICD) market research report forecasts the market to grow at a CAGR of almost 2% during the forecast period. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results